Mario Fernández Montero
About Mario Fernández Montero
Mario Fernández Montero is a Senior Clinical Trial Manager at Bristol Myers Squibb in Madrid, with extensive experience in clinical research and management of onco-hematology trials.
Current Role at Bristol Myers Squibb
Mario Fernández Montero is currently serving as a Senior Clinical Trial Manager at Bristol Myers Squibb in Madrid, Comunidad de Madrid, España. His responsibilities include managing clinical trials, overseeing their implementation, and ensuring that all processes are up to regulatory standards. He contributes significantly to the planning and execution of clinical research projects, supporting the development of new medical treatments.
Previous Experience in Clinical Research
Mario Fernández Montero has extensive experience in clinical research, having previously worked at Valesta on behalf of Celgene and at Celgene directly. Between 2018 and 2021, he served as a Senior Clinical Research Associate in various locations, including Madrid and surrounding areas in España. At Valesta, he held roles such as Clinical Research Associate I and II, and he consulted on behalf of CITRE from 2014 to 2015. He started his career in clinical research as a CRA trainee at Johnson & Johnson's Janssen in 2013.
Educational Background in Clinical Research and Pharmacy
Mario Fernández Montero obtained a Licentiate degree in Pharmacy from Universidad Complutense de Madrid, where he studied from 2005 to 2011. He furthered his education in clinical research by achieving a Master in Clinical Trials Research from Universidad Autónoma de Madrid, which he completed in 2013. His educational background has provided him with a strong foundation in both pharmaceutical sciences and clinical trials management.
Expertise in Onco-Hematology Clinical Trials
Mario Fernández Montero has over five years of experience managing international Phase I dose-finding studies in onco-hematology. His work includes clinical trials for conditions such as Multiple Myeloma and Non-Hodgkin Lymphoma. He has also overseen trials for various solid tumors in addition to hematological malignancies. His role in the global leadership of Clinical Research Associates for Phase I onco-hematology clinical trials highlights his expertise and impact in this specialized field.
Key Contributions to Clinical Research Initiatives
Mario Fernández Montero has made significant contributions to clinical research initiatives, particularly in the implementation of CAR-T therapies for Multiple Myeloma trials in Spain. He also served as a Site Relation Manager for key sites at Celgene, ensuring operational efficiency and effective communication between teams. These roles underscore his ability to manage complex clinical trials and foster strong relations at research sites.